Published in Menopause on July 01, 2010
Estrogen and the prefrontal cortex: towards a new understanding of estrogen's effects on executive functions in the menopause transition. Hum Brain Mapp (2012) 1.12
Sex differences and stress across the lifespan. Nat Neurosci (2015) 1.07
Functional and molecular neuroimaging of menopause and hormone replacement therapy. Front Neurosci (2014) 0.86
The effects of age and estrogen on stress responsivity in older women. Am J Geriatr Psychiatry (2012) 0.83
Stress, inflammation, and aging. Am J Geriatr Psychiatry (2012) 0.81
Cognitive response to estradiol in postmenopausal women is modified by high cortisol. Neurobiol Aging (2011) 0.79
Hormones as "difference makers" in cognitive and socioemotional aging processes. Front Psychol (2015) 0.77
Learning aptitude, spatial orientation and cognitive flexibility tested in a virtual labyrinth after virtual stress induction. BMC Psychol (2015) 0.76
Actions and interactions of estradiol and glucocorticoids in cognition and the brain: Implications for aging women. Neurosci Biobehav Rev (2015) 0.76
Preliminary Hormonal Correlations in Female Patients as a Function of Somatic and Neurological Symptom Clusters: An Exploratory Development of a Multi-Hormonal Map for Bio-Identical Replacement Therapy (MHRT). J Genet Syndr Gene Ther (2013) 0.75
A time to be stressed? Time perspectives and cortisol dynamics among healthy adults. Biol Psychol (2015) 0.75
Menopause Analytical Hormonal Correlate Outcome Study (MAHCOS) and the association to brain electrophysiology (P300) in a clinical setting. PLoS One (2014) 0.75
Socially Housed Female Macaques: a Translational Model for the Interaction of Chronic Stress and Estrogen in Aging. Curr Psychiatry Rep (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 28.61
The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology (1993) 11.24
The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry (1982) 10.83
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet (1996) 7.10
Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA (2002) 6.72
Emotion and cognition: insights from studies of the human amygdala. Annu Rev Psychol (2006) 5.19
Effects of estrogen plus progestin on health-related quality of life. N Engl J Med (2003) 4.83
The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci (2002) 4.14
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA (2004) 3.85
Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry (2006) 3.70
Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry (2006) 3.55
Human emotion and memory: interactions of the amygdala and hippocampal complex. Curr Opin Neurobiol (2004) 3.48
Estrogen actions throughout the brain. Recent Prog Horm Res (2002) 3.17
The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology (2005) 3.15
Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology (2005) 2.92
Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA (2001) 2.32
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology (1997) 2.30
Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci (2005) 2.25
Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med (1998) 2.20
Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol (1994) 2.14
Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychosom Med (1996) 2.09
Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab (2006) 2.03
Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology (Berl) (1985) 2.02
Hormones and mood: from menarche to menopause and beyond. J Affect Disord (2003) 1.99
Estrogen and cognitive functioning in women. Endocr Rev (2003) 1.86
Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev (1998) 1.86
Impaired memory retrieval after psychosocial stress in healthy young men. J Neurosci (2005) 1.82
Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol (2000) 1.80
Monoamine depletion studies: implications for antidepressant discontinuation syndrome. J Clin Psychiatry (2006) 1.57
Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle. Proc Natl Acad Sci U S A (2005) 1.55
Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology (2009) 1.53
The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials (2004) 1.52
Prefrontal cortex as the site of estrogen's effect on cognition. Psychoneuroendocrinology (2001) 1.48
The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels. Pharmacol Biochem Behav (2002) 1.46
Gender differences in the cognitive control of emotion: An fMRI study. Neuropsychologia (2007) 1.44
Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am J Psychiatry (2001) 1.44
Estrogen and cognitive aging in women. Neuroscience (2005) 1.44
Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol (1996) 1.42
The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience (2000) 1.41
Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry (1998) 1.40
Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. Psychosom Med (2001) 1.36
Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr Rev (2009) 1.33
Psychosocial stress induces working memory impairments in an n-back paradigm. Psychoneuroendocrinology (2008) 1.32
Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis. Horm Behav (2007) 1.30
The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab (1991) 1.25
A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life. Neurobiol Aging (2005) 1.24
Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab (1999) 1.21
Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord (2000) 1.21
Estrogen replacement therapy and cognitive function in older women. JAMA (1993) 1.16
Premenopausal and postmenopausal women differ in their cardiovascular and neuroendocrine responses to behavioral stressors. Psychophysiology (1989) 1.16
A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology (1997) 1.13
Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect? Neurology (1997) 1.13
Hormone use and cognitive performance in women of advanced age. J Am Geriatr Soc (2004) 1.11
Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women. Biol Psychiatry (2002) 1.11
A systematic review of clinical trials of hormone therapy on cognitive function: effects of age at initiation and progestin use. Ann N Y Acad Sci (2005) 1.10
Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment. Neuroendocrinology (1999) 1.10
The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology (Berl) (2000) 1.09
Estrogenic effects on memory in women. Ann N Y Acad Sci (1994) 1.08
Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women. Neuropsychopharmacology (2006) 1.08
Mood response to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability. Neuropsychopharmacology (1996) 1.07
Cognitive function in nondemented older women who took estrogen after menopause. Neurology (1998) 1.07
Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol (1991) 1.07
Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am J Obstet Gynecol (1992) 1.06
Mood, depression, and reproductive hormones in the menopausal transition. Am J Med (2005) 1.05
Effects of estrogen variation on neural correlates of emotional response inhibition. Neuroimage (2006) 1.04
Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas (2001) 1.02
Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry (1997) 1.02
Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen. Menopause (2003) 1.01
Long-term estrogen replacement is associated with improved nonverbal memory and attentional measures in postmenopausal women. Fertil Steril (2001) 1.00
Effects on mood of acute phenylalanine/tyrosine depletion in healthy women. Neuropsychopharmacology (2000) 0.99
Estrogen and response to sertraline in postmenopausal women with major depressive disorder: a pilot study. J Psychiatr Res (2006) 0.99
The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women. Obstet Gynecol (1998) 0.98
A 3-day estrogen treatment improves prefrontal cortex-dependent cognitive function in postmenopausal women. Psychoneuroendocrinology (2006) 0.97
Postmenopausal estrogen therapy and depressive symptoms in older women. J Gen Intern Med (2000) 0.96
Estrogen replacement therapy may protect against intellectual decline in postmenopausal women. Horm Behav (1995) 0.95
Postmenopausal hormone replacement: effects on autonomic, neuroendocrine, and immune reactivity to brief psychological stressors. Psychosom Med (1998) 0.95
Low-dose estradiol alters brain activity. Psychiatry Res (2005) 0.95
Fear recognition across the menstrual cycle. Horm Behav (2005) 0.95
Estrogen administration negatively alters mood following monoaminergic depletion and psychosocial stress in postmenopausal women. Neuropsychopharmacology (2007) 0.92
Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. J Clin Psychiatry (2003) 0.89
Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol (1996) 0.87
Effects of experimentally-induced emotional states on frontal lobe cognitive task performance. Neuropsychologia (1999) 0.86
Estrogen effects on the hippocampus and frontal lobes. Int J Fertil Womens Med (2005) 0.86
Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause. Drugs Aging (2003) 0.85
Acute tryptophan depletion in schizophrenia. Psychol Med (2001) 0.83
The effects of transdermal estradiol on the response to mental stress in postmenopausal women: a randomized trial. Am J Med (2000) 0.81
Estrogen therapy and cognition: a 6-year single-blind follow-up study in postmenopausal women. Neurology (2006) 0.80
Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies. J Obstet Gynaecol Res (2005) 0.80
Psychological performance models as indicators of the effects of hypnotic drugs on sleep. Psychopharmacology Suppl (1984) 0.79
Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol (1992) 0.78
Effects of estrogen treatment on sensorimotor task performance and brain dopamine concentrations in gonadectomized male and female CD-1 mice. Horm Behav (1994) 0.78
Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women. Biol Psychiatry (1999) 0.78
Relative influence of subject variables and neurological parameters on neuropsychological performance of adult seizure patients. Arch Clin Neuropsychol (1989) 0.78
Menopause and anxiety: immediate and long-term effects. Menopause (2008) 0.77
The role of estrogen replacement therapy in Alzheimer's disease. Eur J Obstet Gynecol Reprod Biol (2001) 0.77
Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation (2002) 2.46
Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry (2006) 2.13
Effects of lowered serotonin transmission on cocaine-induced striatal dopamine response: PET [¹¹C]raclopride study in humans. Br J Psychiatry (2011) 2.11
Alcohol promotes dopamine release in the human nucleus accumbens. Synapse (2003) 2.06
Ecological momentary assessment: what it is and why it is a method of the future in clinical psychopharmacology. J Psychiatry Neurosci (2006) 1.84
Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One (2009) 1.78
Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Arch Gen Psychiatry (2006) 1.78
Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology (2002) 1.72
Peer review of manuscripts: theory and practice. J Psychiatry Neurosci (2003) 1.65
An examination of DSM-IV depressive symptoms and risk for suicide completion in major depressive disorder: a psychological autopsy study. J Affect Disord (2006) 1.44
Rapid tryptophan depletion as a treatment for acute mania: safety and mechanism of the therapeutic effect. Bipolar Disord (2008) 1.43
Brain serotonin synthesis in MDMA (ecstasy) polydrug users: an alpha-[(11) C]methyl-l-tryptophan study. J Neurochem (2014) 1.40
Appropriate amino acid mixtures for tryptophan depletion and tyrosine/phenylalanine depletion and the safety of long-term amino acid depletion in humans. Psychopharmacology (Berl) (2013) 1.39
Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine. J Neurosci (2007) 1.38
Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry (2002) 1.37
Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis. Horm Behav (2007) 1.30
How to increase serotonin in the human brain without drugs. J Psychiatry Neurosci (2007) 1.27
Peripheral SLC6A4 DNA methylation is associated with in vivo measures of human brain serotonin synthesis and childhood physical aggression. PLoS One (2012) 1.20
Predictors of mood response to acute tryptophan depletion. A reanalysis. Neuropsychopharmacology (2002) 1.14
Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women. Neuropsychopharmacology (2006) 1.08
Acute phenylalanine/tyrosine depletion reduces motivation to smoke cigarettes across stages of addiction. Neuropsychopharmacology (2011) 1.07
The 5HTTLPR polymorphism, psychopathologic symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes. Int J Eat Disord (2005) 1.07
Cocaine craving, euphoria, and self-administration: a preliminary study of the effect of catecholamine precursor depletion. Behav Neurosci (2005) 1.06
Effect of tryptophan hydroxylase-2 gene variants on suicide risk in major depression. Biol Psychiatry (2007) 1.06
Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion. J Psychiatry Neurosci (2007) 1.03
The effect of naltrexone on alcohol's stimulant properties and self-administration behavior in social drinkers: influence of gender and genotype. Alcohol Clin Exp Res (2011) 1.03
alpha-[11C]Methyl-L-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters. Eur Neuropsychopharmacol (2005) 1.03
Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. Arch Gen Psychiatry (2004) 1.02
Racial differences in self-reported infertility and risk factors for infertility in a cohort of black and white women: the CARDIA Women's Study. Fertil Steril (2008) 1.00
Striatal dopamine responses to intranasal cocaine self-administration in humans. Biol Psychiatry (2009) 1.00
Mechanisms of action of estrogen in the brain: insights from human neuroimaging and psychopharmacologic studies. Semin Reprod Med (2009) 1.00
Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men. Neuropsychopharmacology (2004) 1.00
Social behaviour and mood in everyday life: the effects of tryptophan in quarrelsome individuals. J Psychiatry Neurosci (2006) 0.98
A rant against jargon and neologisms. J Psychiatry Neurosci (2006) 0.96
Effects of opioid blockade on the modulation of pain and mood by sweet taste and blood pressure in young adults. Pain (2007) 0.96
Stress-induced dopamine release in human medial prefrontal cortex--18F-fallypride/PET study in healthy volunteers. Synapse (2013) 0.94
Racial and regional differences in age at menopause in the United States: findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Am J Obstet Gynecol (2011) 0.92
STin2 variant and family history of suicide as significant predictors of suicide completion in major depression. Biol Psychiatry (2005) 0.92
Estrogen administration negatively alters mood following monoaminergic depletion and psychosocial stress in postmenopausal women. Neuropsychopharmacology (2007) 0.92
The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers. PLoS One (2012) 0.92
The neurobiology of depression--revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms. Philos Trans R Soc Lond B Biol Sci (2012) 0.91
Understanding emotion regulation in borderline personality disorder: contributions of neuroimaging. J Neuropsychiatry Clin Neurosci (2003) 0.91
Neuropsychological impairments in neuroleptic-responder vs. -nonresponder schizophrenic patients and healthy volunteers. Schizophr Res (2002) 0.91
Ovarian suppression with a gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal. Fertil Steril (2007) 0.90
Bias in the research literature and conflict of interest: an issue for publishers, editors, reviewers and authors, and it is not just about the money. J Psychiatry Neurosci (2009) 0.90
Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association study. Am J Med Genet B Neuropsychiatr Genet (2003) 0.90
Resident experience on reproductive endocrinology and infertility rotations and perceived knowledge. Obstet Gynecol (2011) 0.90
An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study. Neurochem Int (2007) 0.90
Wolfram syndrome and suicide: Evidence for a role of WFS1 in suicidal and impulsive behavior. Am J Med Genet B Neuropsychiatr Genet (2003) 0.89
Bright light exposure during acute tryptophan depletion prevents a lowering of mood in mildly seasonal women. Eur Neuropsychopharmacol (2007) 0.89
Cocaine cue-induced dopamine release in amygdala and hippocampus: a high-resolution PET [¹⁸F]fallypride study in cocaine dependent participants. Neuropsychopharmacology (2013) 0.89
Prolonged and unsoothable crying bouts in infants with and without colic. J Dev Behav Pediatr (2005) 0.89
Association of the promoter polymorphism -1438G/A of the 5-HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosa. Am J Med Genet B Neuropsychiatr Genet (2005) 0.89
The 5HTTLPR polymorphism, prior maltreatment and dramatic-erratic personality manifestations in women with bulimic syndromes. J Psychiatry Neurosci (2007) 0.88
Bioanalytical inaccuracy: a threat to the integrity and efficiency of research. J Psychiatry Neurosci (2010) 0.88
Intrafamilial correspondences on platelet [3H-]paroxetine-binding indices in bulimic probands and their unaffected first-degree relatives. Neuropsychopharmacology (2006) 0.88
The role of dopamine in alcohol self-administration in humans: individual differences. Eur Neuropsychopharmacol (2008) 0.87
Differential striatal dopamine responses following oral alcohol in individuals at varying risk for dependence. Alcohol Clin Exp Res (2013) 0.87
A case-based approach increases student learning outcomes and comprehension of cellular respiration concepts. Biochem Mol Biol Educ (2007) 0.87
Brain serotonin synthesis in adult males characterized by physical aggression during childhood: a 21-year longitudinal study. PLoS One (2010) 0.86
Laxative misuse and behavioral disinhibition in bulimia nervosa. Int J Eat Disord (2003) 0.86
Sweet taste and blood pressure-related analgesia. Pain (2003) 0.86
The neurobiology of depression--revisiting the serotonin hypothesis. II. Genetic, epigenetic and clinical studies. Philos Trans R Soc Lond B Biol Sci (2013) 0.86
Serotonin 1A receptor activation and hypothermia in humans: lack of evidence for a presynaptic mediation. Neuropsychopharmacology (2002) 0.85
Mid-morning tryptophan depletion delays REM sleep onset in healthy subjects. Neuropsychopharmacology (2002) 0.85
Tamoxifen improves cholinergically modulated cognitive performance in postmenopausal women. Neuropsychopharmacology (2013) 0.85
Serotonergic contribution to boys' behavioral regulation. PLoS One (2011) 0.85
Mood stability during acute stimulator challenge in Parkinson's disease patients under long-term treatment with subthalamic deep brain stimulation. Mov Disord (2007) 0.85
No association between the DRD3 Ser9Gly polymorphism and schizophrenia. Schizophr Res (2007) 0.85
Progesterone stimulates cardiac muscle protein synthesis via receptor-dependent pathway. Fertil Steril (2004) 0.85
From anticipation to action, the role of dopamine in perceptual decision making: an fMRI-tyrosine depletion study. J Neurophysiol (2012) 0.84
Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity. Am J Obstet Gynecol (2007) 0.84
Serotonin function, personality-trait variations, and childhood abuse in women with bulimia-spectrum eating disorders. J Clin Psychiatry (2004) 0.84
Effect of D-amphetamine on inhibition and motor planning as a function of baseline performance. Psychopharmacology (Berl) (2010) 0.84
Implications of compulsive and impulsive traits for serotonin status in women with bulimia nervosa. Psychiatry Res (2003) 0.84
Alcohol in a social context: findings from event-contingent recording studies of everyday social interactions. Alcohol Clin Exp Res (2008) 0.84
Lack of effects on core obsessive-compulsive symptoms of tryptophan depletion during symptom provocation in remitted obsessive-compulsive disorder patients. Biol Psychiatry (2005) 0.83
Dopamine and light: dissecting effects on mood and motivational states in women with subsyndromal seasonal affective disorder. J Psychiatry Neurosci (2013) 0.83
Evidence against a role for ovarian hormones in the regulation of blood flow. Fertil Steril (2006) 0.83
Has the time come for clinical trials on the antidepressant effect of vitamin D? J Psychiatry Neurosci (2009) 0.83
The effects of age and estrogen on stress responsivity in older women. Am J Geriatr Psychiatry (2012) 0.83
Increased prevalence of schizophrenia spectrum disorders in relatives of neuroleptic-nonresponsive schizophrenic patients. Schizophr Res (2005) 0.83
CAA insertion polymorphism in the 3'UTR of Nogo gene on 2p14 is not associated with schizophrenia. Brain Res Mol Brain Res (2005) 0.82
Ovarian suppression with gonadotropin-releasing hormone agonist reduces whole body protein turnover in women. Am J Physiol Endocrinol Metab (2006) 0.82
Tryptophan, serotonin and human social behavior. Adv Exp Med Biol (2003) 0.82
The neurobiology of human social behaviour: an important but neglected topic. J Psychiatry Neurosci (2008) 0.82